BIO-key partners with DLT Solutions to enhance cybersecurity for government agencies using innovative IAM solutions and biometrics.
Quiver AI Summary
BIO-key International, Inc. has announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions) to provide its identity and access management solutions to government agencies at all levels in the U.S. This collaboration aims to enhance cybersecurity by incorporating BIO-key's advanced biometric and multi-factor authentication technologies, helping organizations adopt Zero Trust architectures and comply with regulatory standards. The partnership facilitates a streamlined procurement process, enabling agencies to implement robust identity security measures that link digital access directly to individuals rather than merely to devices. Both companies emphasized the importance of collaborating to improve cybersecurity posture and deliver effective identity strategies in response to an evolving threat landscape.
Potential Positives
- Announcement of a strategic partnership with TD SYNNEX Public Sector to provide advanced identity and access management solutions to government agencies.
- The partnership aims to streamline procurement processes for U.S. federal, state, and local government entities, enhancing accessibility to BIO-key's security solutions.
- Integration of BIO-key’s PortalGuard® IAM platform and Passkey:YOU™ biometric solutions into DLT’s government contracts enhances the security posture of public sector agencies.
- This collaboration supports compliance with major government security standards, potentially increasing BIO-key's market presence and credibility in the public sector.
Potential Negatives
- The press release includes a disclaimer regarding forward-looking statements, indicating potential uncertainties and risks associated with the company's future performance, which may concern investors.
- The partnership with TD SYNNEX, while framed positively, suggests BIO-key may rely heavily on external partnerships to penetrate the public sector, potentially indicating limitations in its direct market capabilities.
- The mention of compliance with various government regulations (CJIS, HIPAA, NIST) suggests the possibility of significant operational hurdles or challenges in meeting these standards that could affect implementation timelines and costs.
FAQ
What is the focus of BIO-key's partnership with TD SYNNEX Public Sector?
The partnership aims to deliver advanced identity and access management solutions to government agencies.
How does BIO-key's technology enhance government security?
BIO-key provides biometric authentication and multi-factor authentication to secure digital infrastructure against evolving threats.
What specific solutions does BIO-key offer through this partnership?
Key offerings include biometric authentication, identity and access management tools, and compliance-ready solutions.
How does this partnership support Zero Trust architectures?
The integration of BIO-key's solutions helps government agencies adopt Zero Trust architectures by enhancing identity verification and security.
What benefits do agencies gain from using BIO-key's solutions?
Agencies benefit from improved cybersecurity posture, reduced risks, and streamlined access to critical systems and applications.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BKYI Insider Trading Activity
$BKYI insiders have traded $BKYI stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BKYI stock by insiders over the last 6 months:
- MICHAEL W DEPASQUALE (Chief Executive Officer) has made 2 purchases buying 4,117 shares for an estimated $3,233 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BKYI Hedge Fund Activity
We have seen 10 institutional investors add shares of $BKYI stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA SECURITIES, LLC removed 29,184 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $21,006
- JANE STREET GROUP, LLC added 25,317 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,648
- RENAISSANCE TECHNOLOGIES LLC removed 20,484 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,042
- XTX TOPCO LTD removed 18,829 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,150
- GEODE CAPITAL MANAGEMENT, LLC added 16,271 shares (+49.9%) to their portfolio in Q4 2025, for an estimated $8,771
- UBS GROUP AG added 13,856 shares (+975.1%) to their portfolio in Q4 2025, for an estimated $7,469
- GSA CAPITAL PARTNERS LLP removed 13,314 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,583
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
HOLMDEL, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc . (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions) , a leading technology partner to the U.S. public sector, to bring BIO-key’s comprehensive suite of security solutions to federal, state, and local government agencies. DLT is a unit of TD SYNNEX (NYSE: SNX), a leading global end-to-end distributor of technology products, services and solutions.
As government entities face increasing mandates to adopt Zero Trust architectures and phishing-resistant multi-factor authentication (MFA), the partnership between BIO-key and DLT provides a streamlined procurement path for agencies to secure their digital infrastructure. By integrating BIO-key’s PortalGuard ® IAM platform and Passkey:YOU™ biometric solutions into DLT’s extensive portfolio of government contracts, agencies can now more easily deploy high-assurance identity security that anchors digital access to the actual person, rather than just a device.
“This partnership with BIO-key represents an important step forward in our continued investment in innovative cybersecurity solutions,” said Kirk Fisher, Vice President, Sales, of DLT. “By combining BIO-key’s biometric expertise with DLT’s deep public sector experience, we’re creating new opportunities to deliver scalable, secure identity solutions that meet today’s evolving threat landscape.”
BIO-key’s advanced authentication and access management solutions, including identity-bound biometrics, address the unique challenges of the public sector, including compliance with Criminal Justice Information Services (CJIS), HIPAA, and NIST SP 800-171. Key capabilities now available through the partnership include:
- Biometric Authentication: Patented, phishing-resistant fingerprint technology (NIST-tested and FBI certified) that validates the user's identity independently of their device.
- Identity and Access Management: Centralized control via the PortalGuard platform, providing seamless Single Sign-On (SSO) and authorization across on-premises and cloud environments (IDaaS).
- Multi-Factor Authentication: Enhanced security for mission-critical systems supporting more than twenty authentication methods to fit any agency workflow.
- Compliance-Ready Solutions: Purpose-built to meet rigorous government security standards and regulations while reducing IT help desk costs through self-service tools.
“Partnering with a public sector powerhouse like DLT is a significant milestone in our mission to bring Identity-Bound Biometrics to the forefront of government security,” said Michael DePasquale, Chairman and CEO of BIO-key. “This collaboration strengthens our ability to help agencies improve their cybersecurity posture, reduce risk, and deliver secure, user-friendly access to critical systems across the United States.
“This partnership ensures that public sector customers have access to the expert technical support and contract vehicles necessary to modernize their identity strategies effectively. We look forward to collaborating on joint initiatives and identifying strategic opportunities.”
About TD SYNNEX Public Sector
(
www.DLT.com
)
DLT Solutions is a wholly owned subsidiary of TD SYNNEX (NYSE: SNX), a leading global end-to-end distributor of technology products, services and solutions. DLT is the premier government solutions aggregator with over 30 years of dedication specializing in understanding the IT needs of the federal, state, local and education markets. DLT simplifies the process for software vendors, systems integrators and value-added resellers doing business in the public sector.
DLT provides government agencies and channel partners with the means to transform technology to achieve mission success – all through a secure supply chain. In addition to focusing on the vertical markets listed above, DLT puts an emphasis on six core technology segments: Application and DevOps, Cloud and Infrastructure, CX and Workforce Tools, Cybersecurity and Zero Trust, Data, AI and Automation, and Networking and Edge.
About
BIO-key
International,
Inc.
(
www.BIO-
key.com
)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe
Harbor
Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements, whether as a result of new information, future events, or otherwise.
| Engage with BIO- key: | |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
BIO-key
Resources:
https://www.bio-key.com/portalguard-
2/
https://www.bio-
key.com/biometrics/
https://www.bio-key.com/hardware/
Investor
Contacts:
William Jones, David Collins
Catalyst IR
[email protected]
or 212-924-9800